HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Read responses to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in ADC Online Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Barton, J Search for Related Content PubMed PubMed Citation Articles by Barton, J Topic Collections Relevant Article

Atomoxetine: a new pharmacotherapeutic approach in the management of attention deficit/hyperactivity disorder

Correspondence to:
Correspondence to:
Dr J Barton
North Staffordshire Combined Health Care NHS Trust, Moorlands Team, Abbey Hulton Clinic, Leek Road, Stoke-On-Trent, Staffordshire ST2 8BP, UK; Joanne.Barton{at}nsch-tr.wmids.nhs.uk

ABSTRACT
Atomoxetine is a novel, non-stimulant, highly selective noradrenaline reuptake inhibitor that has been studied for use in the treatment of attention deficit/hyperactivity disorder (ADHD). Data from clinical trials show it to be well tolerated and effective in the treatment of ADHD in children, adolescents, and adults. Improvements were seen not only in core symptoms of ADHD, but also in broader social and family functioning and self esteem. Once-daily dosing of atomoxetine has been shown to be effective in providing continuous symptom relief. Atomoxetine does not appear to have abuse potential and is associated with a benign side effect profile. The development of atomoxetine thus represents an important advance in the pharmacological management of ADHD.

This article has been cited by other articles:

				H. Ashton, P. Gallagher, and B. Moore The adult psychiatrist's dilemma: psychostimulant use in attention deficit/hyperactivity disorder J Psychopharmacol, September 1, 2006; 20(5): 602 - 610. [Abstract] [PDF]

eLetters: